FORMED BY NATURE PERFECTED BY SCIENCE - CORPORATE PRESENTATION - Beleave Presentation copy
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
FORMED BY NATURE
PERFECTED BY SCIENCE
OTCQX: BLEVF
CNSX: BE
CORPORATE
PRESENTATION
June 3, 2019
OUR VISION
Beleave is a leading, global, vertically-integrated
cannabis company that applies scientific methods
and innovation in pursuit of becoming a significant
producer and distributor of cannabis products to meet
the growing domestic and international demand.
Beleave cultivates high-quality cannabis flower and oils,
and is developing additional product lines for 2019.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 2
Who We Are
Patented Scientific Product Production Sales and
Research Development Capacity Distribution
Beleave’s research and Dedicated R&D team Projected production Current provincial supply
development (“R&D”) team focused on developing capacity of over agreements with access to
consists of leading experts products to capitalize on 350,000 sq ft consumers in Ontario,
and includes partnerships concentrates and edibles BC, and Manitoba
with academic institutions. when legalized in Canada Hamilton Phase 2
expansion underway Strategy to capitalize on
Proprietary extraction and Commercial oil international opportunities
processing techniques extraction London, Ontario expansion to supply South American
(patent pending) anticipated for Fall 2019 and European markets
Products in development
Beleave collaborates with include vape cartridges Procannmed partnership in Strategic investments to
academic institutions across and capsules Colombia for South expand its branding,
Ontario. These partnerships American medicinal market cultivation, extraction and
have generated two patent distribution capabilities
applications which are
wholly-owned by Beleave
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 3
Timeline Highlights
Fall 2019
2020
Recreational market anticipated
to expand as commercially
September 6 February 19 manufactured edibles,
October 29 Beleave beverages, and concentrates
Beleave signs
Beleave announces announces Board
agreement to acquire are expected to be
May 10 plans to expand and management
250,000 sq ft of legalized in Canada
Beleave closes into European refresh
greenhouse space and
acquisition of August 21 cannabis market
85 acres of land to
Medi-Green Beleave starts
expand its production
Cannabis Clinic receiving POs
capabilities
Network from Ontario, November 15
BC, and Beleave announces
Manitoba September 26 development of cannabis-
Beleave announces infused powder and sugar
increased investment products for the
agreement for up to recreational market Fall/Winter
$30 million with
Alumina Partners 2019
June 21 London, Ontario
facility expected to
Beleave expands its
come online with
operations into 2019
May 23
120,000 sq ft of
Colombia Beleave receives
indoor greenhouse
approval for Hamilton
grow with 30,000
facility expansion from
sq ft of cannabis
2018 City Council that will
and hemp oil
January 31 yield over 10,000 kg
extraction facility
Beleave awarded per year of high
October 17 ISO 9001 quality cannabis
August 30 Recreational Certification flower product
April 13 July 19 Beleave secures cannabis is
Beleave receives Beleave accelerates its prime location for legalized in
sales license from recreational distribution Saskatchewan Canada
Health Canada strategy by acquiring retail store Click here to read
Seven Oaks our most-recent
press releases
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 4
In the News
February 3, 2019
“Three male employees at cannabis company Beleave Inc. welcomed new
babies to their families last year, and not one took more than two weeks off.”
January 14, 2019
“Video: Getting started in the pot business”
October 17, 2018
Beleave invites cameras into the Hamilton facility for a tour to learn more
about their operations the morning of Canadian cannabis legalization.
October 14, 2018
“Quitting for cannabis: Meet seven
entrepreneurs leaping into green territory.”
September 15, 2018
“People who invest in or work for cannabis companies could be
Beleave in the turned away, a senior U.S. border official says
News September 12, 2018
“Touting London's proximity to highways and its large labour pool, a pot producer
has bought up a greenhouse on a sprawling property in the city's south end.”
Whether it’s a story on August 31, 2018
cannabis employers and “Are you experienced? Lloydminster marijuana
retailer looking for 'qualified' workers.”
entrepreneurs, or a live August 29, 2018
interview the morning “B.C. government has begun to buy bud.”
recreational cannabis
became legal in Canada, August 23, 2018
“Growth on the horizon for licensed pot producers.”
Beleave has had great
newsworthy moments. June 30, 2017
“With a year to go and amid predictions of a looming supply shortage, Health Canada is
scrambling to add capacity once the legalization floodgates swing open.”
Click on any May 10, 2017
story to see “Marijuana startups get new
the full article. funding from 'streaming' deals.”
March 25, 2017
“Hamilton is home to at least three major marijuana cultivators.”
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 5
Facility Expansion Phases
Hamilton, Ontario London, Ontario Colombia Germany
The Hamilton facility hosts growing Existing greenhouse to be retrofitted Beleave has partnered with Beleave has partnered with
space of approximately 3,800 sq ft with 160,000 sq ft of space on an 85 Procannmed in, a license holder for Canymed to supply the German
and continues to be the hub of acre property. the cultivation, production, extraction market with medical cannabis,
extraction, packaging, and of both THC and CBD medical pending government approvals and
distribution. Phase 1 cannabis in Colombia to supply the GMP certification.
Anticipated Early Fall 2019 South American market.
Phase 2 Indoor: 19,000 sq ft Canymed is a German Medical
Expansion plans approved by Hamilty Cannabis company focused on the
City Council on May 22, 2019. Beleave Phase 2 importation and wholesale
will add roughly 100,000 sq ft for Anticipated Late Fall 2019 distribution of medicinal cannabis to
cannabis extraction, processing, and Greenhouse: 34,000 sq ft pharmacies, medical practices and
cultivation. hospitals throughout Germany.
Phase 3
Certifications: Anticipated Early 2020
ISO: Granted January 25, 2019 Greenhouse: 75,950 sq ft
GMP: Anticipated in 2019 Indoor: 5,748 sq ft
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 6
Sales and Distribution
Recreational Distribution
Available Now
BC, MB, ON, SK
Anticipated for 2019
+ AB, QC
Anticipated for 2020
Rest of Canada
100%
Beleave medicinal cannabis is available countrywide
through the Beleave Kannabis Corp label in every
province and territory.
97%
Today, Beleave has recreational cannabis supply
agreements with access to consumers in Ontario, BC, and
Manitoba, representing 55% of the Canadian population.
With the addition of more provinces through to 2020, that
Planned Retail Location number is expected to soar to 97%.
Provincial population percentages based on 2016 Canadian Census
Planned Recreational Online Sales* *Pending government approval
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 7
Sales and Distribution
European Expansion
In October 2018, Beleave partnered with Canymed to supply the German market with medical
cannabis, pending government approvals and GMP certification.
As part of preparation for EU-GMP certification, Beleave’s current Hamilton facility has been pre-
inspected by Cannabis Compliance Inc as per requirements in Eudralex - The Rules Governing
Medicinal Products in the European Union, Volume 4 - Good Manufacturing Practices for
Medicinal Products for Human and Veterinary Use (“EU-GMP”).
• Beleave will receive 10% ownership in Canymed and first right of refusal for
an additional 20% in exchange for providing expertise, training, consultation
and support
• Canymed to import dry flower from Beleave at a target price of €4.00 / g upon
Beleave’s receipt of EU-GMP certification
• Germany has quickly become one of the world's largest federally-regulated
medical cannabis market
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 8
Market Overview
Medical Market Recreational Market
Growing Market Industry Growth
Conservative estimates from Health Canada Recreational market in Canada is expected
predict that the size of the medical cannabis to require cannabis production of over
market will reach 450,000 patients in the 900,000 kg annually to meet its estimated
next six years. value of $8.7 billion in the next six years.
Export Opportunities Retail Distribution
New opportunities are on the horizon for Many provinces will soon be are in the
Canadian license holders to supply foreign process of accepting applications for more
medical markets as many South American point-of-sale locations, and retail distribution
and European nations lack domestic points are expected to grow substantially
production capacity. throughout 2019.
Impactful Research 2021
New Product Lines
Impactful studies highlight the promise
2020 Companies are committing R&D resources
of cannabis to aid in healthy aging, 2019 to develop a wide variety of new product
offerings as the recreational market is anticipated
neurological and degenerative diseases,
and as a powerful weapon against the
2018 to allow for edibles, concentrates, and
2017
opioid crisis. beverage-based cannabis products in 2019.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 9Our Brands
Beleave Kannabis Seven Oaks Medi-Green My Grow Procannmed
Beleave Kannabis, our Seven Oaks, Beleave’s Medi-Green is a leading My Grow is a 3rd party Procannmed is a privately
medicinal label, is available recreational brand, has network of medical cannabis consulting company that held company that is fully
nation-wide. This year, we strong distribution and sales clinics with locations across connects patients across licensed for the cultivation,
plan to leverage research channels in place. Seven Ontario and Quebec. Medi- Canada with compassionate production, extraction and
and new technologies to Oaks appeals to consumers, Green currently has an cannabis physicians who distribution of both
create a suite of highly both conceptually and in active patient base of believe in the therapeutic tetrahydrocannabinol (THC)
focused, proprietary the quality it invokes, approximately 4,000, benefits of cultivating one's and cannabidiol (CBD)
medical products, with attracting them to become with average patient own cannabis as medicine. medical cannabis in
higher margins. returning customers. subscriptions in the range Colombia.
of 2 to 3 grams per day.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 10Our Products
Beleave Kannabis Seven Oaks
Beleave has developed a selection of cannabis products and Seven Oaks is Beleave’s brand for the recreational cannabis market with
offers indica, sativa and hybrid strains at varying price points and products currently sold in Ontario, Manitoba, and British Columbia.
strengths to the Canadian market.
Shishkaberry Cold Creek Kush Ultra Sour
Beleave Kannabis An Indica-dominant hybrid that came Cold Creek Kush is an Indica-dominant This high THC Indica-Dominant Hybrid
from crossing DJ Short Blueberry with hybrid that crosses the powerful MK strain is the result of breeding the Indica-
an unknown Afghani strain. It’s buds Ultra and Chemdawg 91. Piney and Dominant MK Ultra with the Sativa-
Seven Oaks have a fruit and berry aroma with sour, users love its fresh taste and Dominant East Coast Sour Diesel. It’s an
shades of purple. balanced effects. uplifting, best of both worlds strain of
cannabis with THC levels from 13%-20%.
Light green, a speckling of orange and a
strong aroma that’s as sweet as it is sour.
Pink Kush CBD God Bud San Fernando Valley
Pink Kush, derived from its OG Kush Created by mixing an almost pure San Fernando Valley has an energetic
relative, is an indica-dominant hybrid Sativa strain called Hawaiian with a very profile and was bred to provide a more
with strong body- focused effects. Pink strong purple Indica strain. The effects cerebral experience. The bud has light
hairs pop from bright green buds, of God Bud are euphoric and relaxing. green flowers with sparkling trichomes
hardly visible under vast sugar- like and a citrus aroma. San Fernando Valley
trichomes. Sweet vanilla and candy are is a relative of OG Kush and a parent of
the strongest tasting notes. SFV OG.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 11Extraction Laboratory
The design of this laboratory is On November 27, 2018 Beleave This method delivers high purity
based on recent work that has filed a regularly submitted cannabinoid compounds using a
stemmed from research United States patent application simple low-cost process that is
collaborations with principal for the method which involves scalable and efficient. Beleave
investigators at Ryerson the activation, extraction and Kannabis Corp. has been
In October 2018, University, Department of purification of cannabinoid authorized by Health Canada to
Beleave completed the Chemistry and Biology (Dr. active ingredients (including sell cannabis oil products
Lesley Campbell), and which has Δ⁹-tetrahydrocannabinol [THC], effective January 11, 2019.
construction of a new
led to the development by and cannabidiol [CBD]) from
state-of-the-art industrial Beleave of a proprietary (patent- cannabis using only potable
extraction laboratory at pending) and large-scale components and chromatography,
its production facility in industrial method for extraction without organic solvents.
Hamilton, Ontario. and purification of cannabinoid
compounds from plant tissue.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 12Product Development
In November 2018, Patenting
Beleave announced Solubility
it had developed water-
soluble cannabis-infused
Low water solubility of We formulate cannabis R&D being conducted at
powders in preparation extracts or oils makes extracts into soluble, flavour- Beleave's Hamilton facility
for the adult recreational incorporating them into food less powders for use in stems from a patent application
cannabis-infused food products or beverages beverages and food products submitted by Dr. Chen and Dr.
and beverage market difficult and can lead to low using stability-enhancing Rogers, and is owned by
later this year. bioavailability, poor shelf-life, techniques for prolonged Beleave. Manufacturing and
and unpredictable dosing; shelf-life. The final product extraction will be scaled-up to
our patent-pending process offered to consumers will be industrial levels and moved to
Click here to read addresses and solves these a flexible, food-grade Beleave's London, Ontario
the announcement problems. ingredient that delivers an facility in the future.
accurate dose of THC and
CBD when ingested orally.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 13Collaborative Partners
Dr. Lesley Campbell is a Professor in the Department of Chemistry and Biology at Ryerson University. She is
an evolutionary biologist with a strong history studying weedy and invasive plant evolution and currently
possesses a federally issued Industrial Hemp Research License. She has previously worked on industrial C.
LESLEY CAMPBELL, sativa production problems including heritability, maternal effects, phenotypic plasticity and extraction protocols.
PH.D.
Dr. Mohit Bhandari is a world-leading researcher specializing in large international Research Chair at
McMaster University, a University Scholar, and the Associate Chair of Research for Surgery. He was won
Mutually beneficial
numerous awards for contributions to research and evidence-based orthopaedics including the Order of
partnerships produce MOHIT BHANDARI, Ontario, and the Kappa Delta award.
groundbreaking PH.D.
research and innovation
that drives economic
Michael Rogers joined the Department of Food Science in 2014 after holding faculty positions at Rutgers
growth, solves complex
University and the University of Saskatchewan and as the Center Director for the Gastrointestinal Physiology
problems, and creates Center at New Jerseyʼs Institute of Food, Nutrition and Health. He studies molecular gels, self-assembly of
a more skilled MICHAEL ROGERS, nano-fibers and nanotechnology, focusing on delivery of bio-actives and the biophysics of digestion.
workforce. MSC & PH.D. Michael is also the departmentʼs graduate coordinator for the M.Sc. thesis and Ph.D. programs.
As part of a multi-year agreement, Beleave and Niagara University have partnered to provide opportunities
for job placements with graduates from the university’s cannabis program.
INTERNSHIP PROGRAM
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 14Meet the Leadership Team
Bill Panagiotakopoulos Dr. Roger Ferreira Kevin Keagan Justin Kalsaka
Chief Executive Officer, Chief Science Officer Chief Communications Officer, Director of Operations
and Director and Director Interim CFO, and Director
Bill was an early mover in Dr. Ferreira leads Beleave's science Kevin brings extensive experience, Justin is one of the founders
Canada’s cannabis sector and has and innovation program, which has with over 25 years in capital markets of Beleave and is currently
contributed significantly to resulted in the development of working within the financial services responsible for overseeing the
successfully navigating the novel and proprietary methods for industry to provide oversight to cultivation and processing of
regulatory framework to obtain a extraction/purification of the operation, expansion, and Beleave’s cannabis products.
cannabis production and sales cannabinoid compounds, and direction of Beleave's He earned his master’s degree
license. Bill was the founder and methods for soluble cannabinoid communications and capital (MASc) and bachelor’s degree
owner of Cardinal Group Inc, formulations for cannabis food and markets initiatives. As Beleave (BSc) from Ryerson University.
specializing in evaluating drug development. He is also prepares for exciting Justin is experienced in analytical,
opportunities and helping set responsible for developing announcements in the next year, materials, and synthetic chemistry;
strategic goals in business Beleave’s QA program, and has Kevin will provide valuable his interest lies in combining his
development. directly overseen the acquisition of strategic guidance to support the three areas of expertise with
the company’s cultivation, our growth and development. medical marijuana, and he is
processing, and sales licenses always looking for new and
interesting research
opportunities in the field.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 15Meet the Leadership Team
Patience John Amy Nederlander James Wasserstrom Andrew Steane
Quality Assurance Manager Independent Director Independent Director Independent Director
Patience is a dedicated professional Amy is an entrepreneur with Jim has extensive international With over 25 years of software
with over 15 years of experience in extensive experience in strategic experience and expertise in industry experience, Andrew has
quality control and assurance roles business development. She is the governance, compliance and extensive experience in sales,
in the pharmaceutical manufacturing CEO and Co-Founder of L!FE internal control. He spent the early marketing, operations and
industries, and is proficient in Leaders, Inc. which focuses on part of his career in various governance with industry giants
laboratory procedures, GMP/GPP teaching skills for career success. corporate capacities, including as such as Microsoft and SAP. Working
compliance systems and related She also built eProv Studio into a a global partnerships executive for with legal and compliance teams, he
regulations. She is also a trained multi-platform business promoting American Express Travel Related has co-authored global policy
researcher who enjoys researching entrepreneurship and is well known Services. Jim has participated in a documents and managed
various scientific topics to increase for her extensive involvement in the variety of boards and committees governance processes for multi-
her knowledge or to find solutions theater and entertainment business worldwide, predominantly million-dollar marketing budgets.
to problems. Patience holds a M.Sc. having produced a number of focused on governance and Andrew has led sales operations for
degree in microbiology and a Broadway and off-Broadway transparency. a software business in excess of
graduate certificate in biotechnology productions. Amy has an MBA from $800M in revenue, identifying key
from McGill University, Quebec. Columbia Business School and a business trends used to set
Bachelors form the University of strategic direction across a global
Michigan. organization.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 16KEY TAKEAWAYS
•Canadian-based vertically integrated •Recreational sales in 4 provinces
cannabis company currently, expanding to 8 in 2020
•Presence in three continents; North •Expanding medical distribution
American, South America, and Europe channels internationally
•Licensed for cultivation, processing, •Industry-leading yields with low
and sale for medical purposes; cannabis production costs
plants and seeds, fresh cannabis, dried
cannabis, and cannabis oil •Passionate, experienced, and industry-
connected leadership team
•Developing new products for 2019
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 17LET’S CONNECT INVESTOR CONTACTS
Bill Panagiotakopoulos
CHIEF EXECUTIVE OFFICER
905 979 4835
BILL@BELEAVE.COM
Kevin Keagan
CHIEF COMMUNICATIONS OFFICER
647 449 7352
KKEAGAN@BELEAVE.COM
Click on a social
media outlet to
see our profile and
follow Beleave.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 18DISCLAIMER
Readers should rely only on information contained or incorporated by reference in the short form prospectus. The Company has not
authorized anyone to provide the reader with different information. The Company is not making an offer of these securities in any
jurisdiction where the offer is not permitted. Readers should not assume that the information contained or incorporated by reference in the
short form prospectus is accurate as of any date other than the date on the front of the short form prospectus or the respective dates of the
documents incorporated by reference therein. The Company does not undertake to update the information contained or incorporated by
reference in the short form prospectus, except as required by applicable securities laws.
This presentation includes data obtained from independent industry publications, market research and analyst reports, surveys and other
publicly available sources. Although the Company, believe these sources to be generally reliable, such information is subject to
interpretation and cannot be verified with complete certainty due to limits on the availability and reliability of raw data, the voluntary nature
of the data gathering process and other limitations and uncertainties inherent in any report or survey. Accordingly, the accuracy and
completeness of this data is not guaranteed. The Company has not independently verified any of the data from third party sources referred
to in this presentation nor ascertained the underlying assumptions relied upon by such sources.
NOTICE
A preliminary short form prospectus containing important information relating to the securities described in this document has been filed
and the securities regulatory authorities in the provinces of British Columbia, Alberta, and Ontario. A copy of the preliminary short form
prospectus and any amendment, is required to be delivered with this document. The preliminary short form prospectus is still subject to
completion. There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final short form prospectus
has been issued. This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read
the preliminary short form prospectus, final short form prospectus and any amendment, for disclosure of those facts, especially risk factors
relating to the securities offered before making an investment decision.
June 2019 OTCQX: BLEVF
Beleave Inc.
www.beleave.com CNSX: BE 19You can also read
